BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19739081)

  • 21. Immunotherapeutic strategies for hepatocellular carcinoma.
    Butterfield LH
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S232-41. PubMed ID: 15508089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diminution of the number of gamma delta T lymphocytes in hepatocellular carcinoma patients treated with transcatheter arterial embolization].
    Akizuki S; Magara T; Tanaka T
    Nihon Rinsho Meneki Gakkai Kaishi; 1998 Jun; 21(3):108-17. PubMed ID: 9754013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of alpha-fetoprotein-derived peptides recognized by cytotoxic T lymphocytes in HLA-A24+ patients with hepatocellular carcinoma.
    Mizukoshi E; Nakamoto Y; Tsuji H; Yamashita T; Kaneko S
    Int J Cancer; 2006 Mar; 118(5):1194-204. PubMed ID: 16152611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficacy of transcatheter arterial infusion chemotherapy and transcatheter arterial embolization in 132 patients with primary hepatocellular carcinoma].
    Shi Z; Guo Y; Liu D
    Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):211-3. PubMed ID: 11776839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of fructose 1,6-diphosphate aldolase to detect tumour necrosis after transcatheter arterial embolization of hepatocellular carcinoma.
    Khan KN; Nakata K; Kusumoto Y; Nakao K; Kato Y; Nagataki S
    J Gastroenterol Hepatol; 1998 Feb; 13(2):192-6. PubMed ID: 10221823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of transcatheter arterial embolization in terms of serum alpha-fetoprotein doubling time in hepatocellular carcinoma].
    Kanno T; Harihara S; Kim K; Kimura S; Tamori A; Kuroki T; Mizoguchi Y; Kobayashi K; Monna T; Nakamura K
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):683-7. PubMed ID: 2451472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcatheter arterial embolization for hepatocellular carcinoma with portal vein thrombosis.
    Yen FS; Wu JC; Kuo BI; Chiang JH; Chen TZ; Lee SD
    J Gastroenterol Hepatol; 1995; 10(3):237-40. PubMed ID: 7548796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time courses of PIVKA-II and AFP levels after hepatic artery embolization and hepatic artery infusion against hepatocellular carcinoma: relation between the time course and tumor necrosis.
    Kishi K; Sonomura T; Mitsuzane K; Nishida N; Kimura M; Satoh M; Yamada R; Kodama N; Kinoshita M; Tanaka H
    Radiat Med; 1992; 10(5):189-95. PubMed ID: 1279748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T-cell responses to HLA-A*0201 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancer.
    Butterfield LH; Ribas A; Meng WS; Dissette VB; Amarnani S; Vu HT; Seja E; Todd K; Glaspy JA; McBride WH; Economou JS
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5902-8. PubMed ID: 14676113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of nontumorous tissue damage by transcatheter arterial embolization for hepatocellular carcinoma.
    Khan KN; Nakata K; Kusumoto Y; Shima M; Ishii N; Koji T; Nagataki S
    Cancer Res; 1991 Oct; 51(20):5667-71. PubMed ID: 1717151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of alpha-fetoprotein-specific CD4- and CD8-mediated T-cell response using RNA-transfected dendritic cells.
    Zhang HM; Zhang LW; Ren J; Fan L; Si XM; Liu WC
    Cell Immunol; 2006 Feb; 239(2):144-50. PubMed ID: 16814271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of percutaneous ethanol injection for postoperative recurrence of hepatocellular carcinoma in combination with transcatheter arterial embolization.
    Ishii H; Okada S; Sato T; Nose H; Okusaka T; Yoshimori M; Takayasu K; Takayama T; Kosuge T; Yamasaki S
    Hepatogastroenterology; 1996; 43(9):644-50. PubMed ID: 8799409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-fetoprotein in patients with hepatocellular carcinoma after transcatheter arterial embolization.
    Hsieh MY; Lu SN; Wang LY; Liu TY; Su WP; Lin ZY; Chuang WL; Chen SC; Chang WY
    J Gastroenterol Hepatol; 1992; 7(6):614-7. PubMed ID: 1283085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of transcatheter arterial embolization in patients with resectable hepatocellular carcinoma: a nation-wide, multicenter study.
    Huang YH; Chen CH; Chang TT; Chen SC; Wang SY; Lee PC; Lee HS; Lin PW; Huang GT; Sheu JC; Tsai HM; Chau GY; Chiang JH; Lui WY; Lee SD; Wu JC
    Liver Int; 2004 Oct; 24(5):419-24. PubMed ID: 15482337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bland embolization of hepatocellular carcinoma using superabsorbent polymer microspheres.
    Osuga K; Hori S; Hiraishi K; Sugiura T; Hata Y; Higashihara H; Maeda N; Tomoda K; Nakamura H
    Cardiovasc Intervent Radiol; 2008; 31(6):1108-16. PubMed ID: 18543028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunobiology and gene-based immunotherapy of hepatocellular carcinoma.
    Geissler M; Mohr L; Ali MY; Grimm CF; Ritter M; Blum HE
    Z Gastroenterol; 2003 Nov; 41(11):1101-10. PubMed ID: 14648380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides.
    Butterfield LH; Ribas A; Dissette VB; Lee Y; Yang JQ; De la Rocha P; Duran SD; Hernandez J; Seja E; Potter DM; McBride WH; Finn R; Glaspy JA; Economou JS
    Clin Cancer Res; 2006 May; 12(9):2817-25. PubMed ID: 16675576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association Between High-Avidity T-Cell Receptors, Induced by α-Fetoprotein-Derived Peptides, and Anti-Tumor Effects in Patients With Hepatocellular Carcinoma.
    Nakagawa H; Mizukoshi E; Kobayashi E; Tamai T; Hamana H; Ozawa T; Kishi H; Kitahara M; Yamashita T; Arai K; Terashima T; Iida N; Fushimi K; Muraguchi A; Kaneko S
    Gastroenterology; 2017 May; 152(6):1395-1406.e10. PubMed ID: 28188748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of dendritic cells by local ablation of hepatocellular carcinoma.
    Ali MY; Grimm CF; Ritter M; Mohr L; Allgaier HP; Weth R; Bocher WO; Endrulat K; Blum HE; Geissler M
    J Hepatol; 2005 Nov; 43(5):817-22. PubMed ID: 16087270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A long surviving hepatocellular carcinoma case (2 years 1 month) with tumor thrombus in the portal trunk treated by embolization].
    Hara H; Okazaki M; Ono Y; Nakamura T; Oda Z
    Rinsho Hoshasen; 1989 Dec; 34(13):1641-4. PubMed ID: 2560084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.